{"id":9898,"date":"2022-07-05T02:00:00","date_gmt":"2022-07-05T02:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3808029_CN08029_0"},"modified":"2022-07-05T02:00:00","modified_gmt":"2022-07-05T02:00:00","slug":"qunasys-co-hosts-industry-government-leaders-for-pistoia-alliance-global-knowledge-sharing-virtual-event","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=9898","title":{"rendered":"QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event"},"content":{"rendered":"
\n\n\n\n
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Event focuses on real-world use cases for new technologies, including quantum, poised to improve health and the life sciences<\/i><\/p>\n

TOKYO<\/span>, July 5, 2022 \/PRNewswire\/ — QunaSys, a global leader in the development of innovative quantum algorithms in chemistry and a Pistoia Alliance member company, will co-host the Pistoia Alliance Global Knowledge-Sharing event held on<\/span> July 7<\/span>, which will bring together scientific, business and government leaders from Japan<\/span> and around the world to improve innovation in health and the life sciences.<\/span><\/p>\n

\n

\"QunaSys<\/a>
QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event<\/span><\/p>\n<\/p><\/div>\n

The Pistoia Alliance is a global, not-for-profit alliance that works to lower barriers to innovation in life science and healthcare R&D. The Alliance has organized these webinars to provide specific examples of where its pre-competitive collaboration model of shared-risk and shared-reward can bring value and support to<\/span> improve life sciences and health through science and innovation.<\/p>\n

Quantum computing is one of the technologies that is positioned to make dramatic improvements in the fields of health and the life sciences, particularly in the field of pharma. <\/p>\n

QunaSys CEO and co-founder Tennin Yan will discuss emerging use cases and how quantum is poised to impact the future of pharma R&D. He will participate on the future of pharma R&D panel discussion, which will be facilitated by John Bolger<\/span>, CEO of Matador, a Pistoia Alliance member company, along with industry experts from Daiichi Sankyo, Preferred Networks and Mitsubishi Tanabe Pharma Corporation and the Pistoia Alliance.<\/p>\n

Hiroki Oka<\/span>, of QunaSys, will join a panel discussion on the future of pharma R&D \/ pre-competitive open innovation and the role of emerging science and technology.<\/p>\n

The event will also feature keynote sessions from prominent scientists, government officials and business leaders.<\/p>\n

The keynote sessions are:<\/p>\n